Analyst Consensus ?
ConsensusHold37 ratings
Bullish1129.7%
Neutral2054.1%
Bearish616.2%
Molson Coors Beverage Company · TAP · FY2026 Q1 · Calendar Q2 2026
Molson Coors Beats EPS Estimates, Reaffirms Guidance Amid Cost Pressures
Molson Coors delivered a strong bottom-line beat in Q1 FY2026, with EPS of $0.62 more than doubling the $0.36 consensus, driven by cost-savings progress and favorable mix. Revenue was essentially in line at $2.35 billion versus $2.33 billion expected. Management reaffirmed full-year guidance and struck a confident tone, emphasizing the Horizon 2030 strategy, the newly acquired Monaco Cocktails RTD platform, and aggressive summer media spend tied to the World Cup. However, persistent cost headwinds from the Midwest premium and aluminum inflation, ongoing supply-chain disruptions, and share erosion in the value segment temper the outlook. The stock's muted initial reaction and subsequent drift of roughly 7.5% lower suggest investors are waiting for evidence that volume growth and margin protection can coexist.
Reported Before market openNYSEConsumer Defensive
$7.79B market cap
100quality score
Company context
Snapshot as of publicationMolson Coors Beverage Company is a global entity engaged in the production, marketing, and sale of a diverse range of beer and other malt-based beverages. Its extensive operations span the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company's product lineup also features flavored malt beverages, craft beers, and convenient ready-to-drink selections. Founded in 1774, the firm, headquartered in Golden, Colorado, was previously known as Molson Coors Brewing Company before officially adopting its current name, Molson Coors Beverage Company, in January 2020.
Earnings scorecard
Reported versus consensus
Reported EPS
$0.62
Consensus $0
EPS surprise
+72.2%
Reported versus consensus
Reported revenue
$2.35B
Consensus $2.33B
Revenue surprise
+1.0%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$41.56Current
$40Low
$53.68Average
$75High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 14, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 8, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 5, 2026 |
| Barclays | Underweight | Underweight | Maintain | May 4, 2026 |
| Needham | Buy | Buy | Maintain | May 1, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| B of A Securities | Underperform | Neutral | Downgrade | Feb 25, 2026 |
| TD Cowen | Hold | Hold | Maintain | Feb 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Feb 19, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 19, 2026 |
| Roth Capital | Buy | Buy | Maintain | Nov 5, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Nov 5, 2025 |
| Jefferies | Hold | Hold | Maintain | Nov 5, 2025 |
| Bernstein | Market Perform | Market Perform | Maintain | Nov 5, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 2, 2025 |
| Wedbush | Neutral | Neutral | Maintain | Nov 6, 2023 |
| Roth MKM | Buy | Buy | Maintain | Oct 4, 2023 |
| CFRA | Buy | Hold | Upgrade | May 2, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Feb 22, 2023 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jan 6, 2023 |
| Bryan Garnier | Sell | Buy | Downgrade | Sep 1, 2022 |
| Redburn Partners | Neutral | Sell | Upgrade | Jul 13, 2022 |
| MKM Partners | Buy | Buy | Maintain | Apr 6, 2020 |
| Guggenheim | Buy | Neutral | Upgrade | Mar 20, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Nov 26, 2019 |
| Redburn | Sell | Neutral | Downgrade | Oct 11, 2019 |
| Bank of America | Underperform | Buy | Downgrade | Jul 15, 2019 |
| Susquehanna | Positive | Positive | Maintain | Aug 2, 2018 |
| Stifel Nicolaus | Hold | Buy | Downgrade | May 17, 2018 |
| Stifel | Hold | Buy | Downgrade | May 17, 2018 |
| Berenberg | Hold | Sell | Upgrade | Feb 8, 2018 |
| Societe Generale | Hold | Buy | Downgrade | May 4, 2017 |
| Nomura | Neutral | Buy | Downgrade | Jun 23, 2015 |
| BTIG Research | Neutral | Buy | Downgrade | Sep 9, 2014 |
| BTIG | Neutral | Buy | Downgrade | Sep 9, 2014 |
| ISI Group | Buy | Neutral | Upgrade | May 16, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $41.56. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $41 | $41.18 | -1.3% | Jul 22, 2026 |
| UBS | Analyst unavailable | $40 | $40.86 | -3.8% | Jul 16, 2026 |
| Wells Fargo | Analyst unavailable | $41 | $39.27 | -1.3% | Jul 8, 2026 |
| Morgan Stanley | Eric Serotta | $46 | $41.46 | +10.7% | May 4, 2026 |
| Barclays | Analyst unavailable | $41 | $42.14 | -1.3% | May 4, 2026 |
| Deutsche Bank | Steve Powers | $42 | $42.74 | +1.1% | May 1, 2026 |
| Barclays | Analyst unavailable | $43 | $44.54 | +3.5% | Apr 14, 2026 |
| UBS | Analyst unavailable | $52 | $49.21 | +25.1% | Feb 20, 2026 |
| Jefferies | Analyst unavailable | $45 | $48.17 | +8.3% | Feb 19, 2026 |
| Piper Sandler | Analyst unavailable | $45 | $50.81 | +8.3% | Feb 19, 2026 |
| Roth Capital | Analyst unavailable | $58 | $50.81 | +39.6% | Feb 19, 2026 |
| Wells Fargo | Analyst unavailable | $54 | $53.22 | +29.9% | Feb 17, 2026 |
| Barclays | Analyst unavailable | $49 | $49.05 | +17.9% | Jan 16, 2026 |
| BNP Paribas | Analyst unavailable | $40 | $50.64 | -3.8% | Jan 16, 2026 |
| UBS | Analyst unavailable | $50 | $49.64 | +20.3% | Jan 14, 2026 |
| Piper Sandler | Analyst unavailable | $50 | $45.47 | +20.3% | Nov 21, 2025 |
| Wells Fargo | Analyst unavailable | $50 | $46.45 | +20.3% | Nov 19, 2025 |
| Evercore ISI | Robert Ottenstein | $50 | $44.67 | +20.3% | Nov 5, 2025 |
| Roth Capital | Analyst unavailable | $65 | $44.83 | +56.4% | Nov 5, 2025 |
| Jefferies | Kaumil Gajrawala | $48 | $43.67 | +15.5% | Nov 4, 2025 |
| Needham | Analyst unavailable | $54 | $43.31 | +29.9% | Nov 3, 2025 |
| UBS | Peter Grom | $49 | $45.85 | +17.9% | Oct 8, 2025 |
| Piper Sandler | Michael Lavery | $52 | $45.76 | +25.1% | Sep 30, 2025 |
| Roth Capital | William Kirk | $71 | $56.95 | +70.8% | May 20, 2025 |
| Barclays | Lauren Lieberman | $61 | $60.96 | +46.8% | Mar 27, 2025 |
| Wells Fargo | Chris Carey | $74 | $60.03 | +78.1% | Nov 8, 2024 |
| Piper Sandler | Michael Lavery | $59 | $52.1 | +42.0% | Aug 7, 2024 |
| Piper Sandler | Michael Lavery | $57 | $53.07 | +37.2% | Jul 19, 2024 |
| Barclays | Lauren Lieberman | $47 | $53.98 | +13.1% | Jul 18, 2024 |
| Bernstein | Trevor Stirling | $61 | $51.24 | +46.8% | Jul 14, 2024 |
| Evercore ISI | Robert Ottenstein | $68 | $57.26 | +63.6% | Apr 30, 2024 |
| Barclays | Lauren Lieberman | $67 | $67.81 | +61.2% | Apr 12, 2024 |
| Goldman Sachs | Bonnie Herzog | $75 | $66.63 | +80.5% | Apr 9, 2024 |
| Piper Sandler | Michael Lavery | $69 | $67.24 | +66.0% | Mar 22, 2024 |
| Cowen & Co. | Analyst unavailable | $60 | $49.58 | +44.4% | Jan 6, 2023 |
| Deutsche Bank | Steve Powers | $50 | $54.5 | +20.3% | Dec 6, 2022 |
| Bryan Garnier & Co Ltd | Nikolaas Faes | $54 | $51.67 | +29.9% | Sep 1, 2022 |
| Goldman Sachs | Bonnie Herzog | $54 | $55.38 | +29.9% | Jun 28, 2022 |
| Cowen & Co. | Vivien Azer | $55 | $55.86 | +32.3% | Jun 24, 2022 |
| Deutsche Bank | Analyst unavailable | $51 | $54.25 | +22.7% | Apr 27, 2022 |
| MKM Partners | William Kirk | $64 | $49.05 | +54.0% | Feb 24, 2022 |
| Cowen & Co. | Vivien Azer | $50 | $44.5 | +20.3% | Nov 1, 2021 |
| Goldman Sachs | Bonnie Herzog | $42 | $43.42 | +1.1% | Oct 29, 2021 |
| Evercore ISI | Robert Ottenstein | $55 | $43.42 | +32.3% | Oct 29, 2021 |
| Guggenheim | Laurent Grandet | $75 | $48.31 | +80.5% | Jul 29, 2021 |
| Bernstein | Trevor Stirling | $74 | $56.47 | +78.1% | May 24, 2021 |
Track every rating change on TAP the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
+0.8%
Event window
SPY move
+1.0%
Same window
Abnormal move
-0.2%
Stock minus SPY
Volume
2.2×
Versus trailing sessions
Subsequent drift
-7.5%
Up to 20 sessions
TAPSPY benchmark
Follow TAP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
In the prior quarter, management introduced the Horizon 2030 plan with a $450 million cost-savings program, expanded share repurchase authorization to $4 billion, and flagged Midwest premium and aluminum cost pressure as 2026 margin headwinds. This quarter, the company delivered on the bottom line with a 72% EPS beat, reaffirmed guidance, and added the Monaco Cocktails acquisition to expand its RTD portfolio. Capex outlook shifted from decreasing to stable. New product actions include re-launching Keystone Apple and re-introducing Keystone Ice to address value-segment share loss. World Cup-linked marketing activations were detailed as a near-term growth lever. The core narrative is unchanged, but execution is progressing with measurable bottom-line results.
Guidance delta
FY2026 full-year guidance was reaffirmed, consistent with the prior quarter's maintained guidance sentiment. Management did not raise guidance despite the significant EPS beat, indicating caution around ongoing Midwest premium and aluminum cost pressures and macro uncertainty.
Key takeaways
- EPS of $0.62 beat the $0.36 consensus by 72%, driven by cost savings and favorable mix
- Revenue of $2.35 billion slightly exceeded the $2.33 billion estimate; sales were flat year-over-year on a constant-currency basis
- FY2026 full-year guidance was reaffirmed despite ongoing Midwest premium and aluminum cost pressures
- Monaco Cocktails acquisition adds an RTD platform, expanding the beyond-beer portfolio alongside Topo Chico Hard and Fever-Tree
- Underlying pretax income rose 16% and EPS increased 24% year-over-year
- Net debt/EBITDA remained at approximately 2.5x, with ongoing share repurchases and a raised dividend
Management priorities
- Execute Horizon 2030 strategic pillars: portfolio revitalization, local accountability, and digital capabilities
- Deliver $450 million in cost savings over three years across all business units
- Integrate Monaco Cocktails and expand RTD distribution
- Deploy World Cup and summer sport marketing activations in English and Spanish
- Continue share repurchases and incremental dividend increases under the $4 billion authorization
- Invest in technology and ERP modernization
Related earnings events
Consumer DefensiveSources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-31T21:01:27.339563+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T21:01:27.336820+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.